Nadine Dragin
- Molecular Biology
- Neurology top 5%
- Health, Toxicology and Mutagenesis top 5%
- Pharmacology top 1%
- Immunology top 10%
- Co-authors
- Daniel W. NebertSonia Berrih‐AkninRozen Le PanseShigeyuki UnoTimothy P. DaltonMarian L. MillerZhanquan ShiJosé Adolfo Villegas
- Topics
- Myasthenia Gravis and Thymoma (11 papers)Carcinogens and Genotoxicity Assessment (7 papers)Pharmacogenetics and Drug Metabolism (7 papers)
- Partner nations
- FranceUnited StatesSweden
In The Last Decade
Nadine Dragin
30 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 112
- Molecular Biology 394
- Neurology 336
- Health, Toxicology and Mutagenesis 324
- Pharmacology 280
- Immunology 273
Countries citing papers authored by Nadine Dragin
This map shows the geographic impact of Nadine Dragin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nadine Dragin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nadine Dragin more than expected).
Fields of papers citing papers by Nadine Dragin
This network shows the impact of papers produced by Nadine Dragin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nadine Dragin. The network helps show where Nadine Dragin may publish in the future.
Co-authorship network of co-authors of Nadine Dragin
This figure shows the co-authorship network connecting the top 25 collaborators of Nadine Dragin. A scholar is included among the top collaborators of Nadine Dragin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nadine Dragin. Nadine Dragin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 5 | |
| 4 | 61 | |
| 5 | 42 | |
| 6 | 21 | |
| 7 | 46 | |
| 8 | 10 | |
| 9 | 110 | |
| 10 | 50 | |
| 11 | 40 | |
| 12 | 55 | |
| 13 | 63 | |
| 14 | 27 | |
| 15 | 90 | |
| 16 | 73 | |
| 17 | 38 | |
| 18 | 53 | |
| 19 | 174 | |
| 20 | 29 |
About Nadine Dragin
Nadine Dragin is a scholar working on Pharmacology, Neurology and Endocrinology, Diabetes and Metabolism, having authored 32 papers that have together received 1.6k indexed citations. Recurring topics across this work include Myasthenia Gravis and Thymoma (11 papers), Carcinogens and Genotoxicity Assessment (7 papers) and Pharmacogenetics and Drug Metabolism (7 papers). The work is most often cited by research in Pharmacology (280 citations), Health, Toxicology and Mutagenesis (324 citations) and Neurology (336 citations). Nadine Dragin has collaborated with scholars based in France, United States and Sweden. Frequent co-authors include Daniel W. Nebert, Sonia Berrih‐Aknin, Rozen Le Panse, Shigeyuki Uno, Timothy P. Dalton, Marian L. Miller, Zhanquan Shi, José Adolfo Villegas, Frank J. Gonzalez and Marina Gálvez‐Peralta. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Reviews Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.